Previous article Table of Contents  Next article

LETTER TO EDITOR
Year : 2014  |  Volume : 8  |  Issue : 1  |  Page : 143-144

Hyperhomocysteinemia: Anesthetic concerns


Department of Anaesthesiology and Intensive Care, Govind Ballabh Pant Hospital, New Delhi, India

Correspondence Address:
Mritunjay Kumar
Department of Anaesthesiology and Intensive Care, Govind Ballabh Pant Hospital, New Delhi - 110 002
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1658-354X.125982

Rights and Permissions
Date of Web Publication1-Feb-2014
 


How to cite this article:
Aggarwal S, Verma S, Singh B, Kumar M. Hyperhomocysteinemia: Anesthetic concerns. Saudi J Anaesth 2014;8:143-4

How to cite this URL:
Aggarwal S, Verma S, Singh B, Kumar M. Hyperhomocysteinemia: Anesthetic concerns. Saudi J Anaesth [serial online] 2014 [cited 2019 Dec 6];8:143-4. Available from: http://www.saudija.org/text.asp?2014/8/1/143/125982

Sir,

Homocystinuria is an inherited autosomal recessive metabolic disorder, which occurs due to deficiency of enzymes (methionine synthase, cystathionine β synthase) involved in methionine metabolism. [1] Homocysteinemia, a separate, but related entity, may be due to similar genetic pre-disposition or in association with chronic renal failure, hypothyroidism, malignancies, methotrexate treatment, oral contraceptive use, and smoking. Hyperhomocysteinemia predisposes to coronary and cerebrovascular thrombotic disease. [2]

A 28-year-old male patient presented to us with jejunal obstruction and was subsequently posted for laparotomy. He was a known case of coronary artery disease (CAD), but was not receiving any medications and his Echocardiography showed CAD, dilated left ventricle (LV) with regional wall motion abnormalities in left anterior descending and left circumflex territories, severe LV dysfunction with ejection fraction of 30-35%. During investigation, for prothrombotic state following values were noted: Homocysteine levels of 25.37 μmol/l (3.7-13.9 μmol/l), factor VIII levels 396% (70-150%), C-reactive protein levels of 22.5 mg/l (0-5 mg/l), protein C (78.1%), protein S (92%), factor V Leiden (148%), and factor IX (98.4%). Lipid profile, coagulation profile, and lower limb venous Doppler study was normal.

Pre-operatively, he was started on aspirin, atorvastatin, carvedilol, folic acid, pyridoxine, methylcobalamin, and enoxaparin. Adequate hydration and ambulation were also assured. In the operation theater, other than routine monitors, invasive blood pressure, and cardiac output monitoring using the flotrac/vigileo TM device (Edwards Lifesciences, Irvine, CA, USA) was carried out continuously. Pneumatic compression devices were applied on both legs. Modified rapid sequence induction of anesthesia was carried out with fentanyl, propofol, and rocuronium. He received oxygen, air, sevoflurane for maintenance. Induction was marked by hypotension and decrease in cardiac output and was managed by lactated ringer, intermittent boluses of mephentermine and dopamine infusion, titrated according to stroke volume variation, systemic vascular resistance index, and cardiac output respectively. One episode of hypoglycemia was also noted despite continuous infusion of 25% dextrose. After completion of resection and anastomosis and tracheal extubation, dopamine could be tapered off. In post-operative period, adequate analgesia was ensured, invasive and glucose monitoring, deep venous thrombosis (DVT) prophylaxis and all his pre-operative medications were continued. His further stay in the hospital was uneventful.

Homocysteinemia is associated with thromboembolic complications by causing endothelial dysfunction, increasing procoagulant activity and decreasing antithrombotic effect. It decreases protein C activation rate, resistance of endothelium to thrombosis and reduces vasodilatory effect of nitric oxide and thereby promotes thrombosis. [3] It increases chances of premature atherosclerosis involving cardiovascular system, central nervous system, renal vein, and peripheral veins.

Challenges related with our case were history of CAD with poor myocardial function, a prothrombotic state necessitating perioperative anticoagulation, increased risk of perioperative adverse cardiovascular or cerebrovascular events and need to bring down homocysteine levels pre-operatively to decrease thrombotic complications. There was an added risk of aspiration and urgency for surgery due to nature of disease.

DVT prophylaxis, active ambulation, and good hydration used pre-operatively decreased risk of perioperative thromboembolic complications. Oral pyridoxine, folic acid, and vitamin B12 were given as they have been known to decrease rise in homocysteine levels. [4] Intraoperative steps taken were maintenance of euvolemia and hemodynamics. Nitrous oxide was avoided as it inhibits the enzyme methionine synthase and leads to accumulation of homocysteine. Badner et al. [5] compared patients anesthetized with and without nitrous oxide and found 12-24 μmol/l increase in plasma homocysteine levels. He also observed significantly increased incidence and duration of post-operative ischemia in patients' anesthetized with nitrous oxide. Hypoglycemia is a known complication as methionine causes insulin release. Care was taken at the time of patient positioning as these patients have increased risk of osteoporosis. Adequate analgesia, thromboprophylaxis, and euglycemia ensured uneventful post-operative recovery.

 
  References Top

1.Behman RE, Kliegman RM, Jenson HB. Nelson Textbook of Pediatrics. 16 th ed. Philadelphia: W. B. Saunders Co.; 2000. p. 351.  Back to cited text no. 1
    
2.Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 2004;177:375-81.  Back to cited text no. 2
[PUBMED]    
3.Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: An overview. Arch Pathol Lab Med 2007;131:872-84.  Back to cited text no. 3
[PUBMED]    
4.Badner NH, Freeman D, Spence JD. Preoperative oral B vitamins prevent nitrous oxide-induced postoperative plasma homocysteine increases. Anesth Analg 2001;93:1507-10.  Back to cited text no. 4
[PUBMED]    
5.Badner NH, Beattie WS, Freeman D, Spence JD. Nitrous oxide-induced increased homocysteine concentrations are associated with increased postoperative myocardial ischemia in patients undergoing carotid endarterectomy. Anesth Analg 2000;91:1073-9.  Back to cited text no. 5
[PUBMED]    




 

Top
 
Previous article    Next article
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  IN THIS Article
   References

 Article Access Statistics
    Viewed1454    
    Printed12    
    Emailed1    
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal